Fran Magee is listed as an executive officer on 8 SEC Form D filings by 2 issuers between Jul 2015 and Jun 2026: Spine BioPharma, Inc. (New York, NY — pharmaceuticals — 2022–2026; $13.5M reported sold to 14 investors) and Woven Orthopedic Technologies, LLC (Manchester, CT — other health care — 2015; $10.7M reported sold to 76 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 11 years. Across those companies the filings report $24.2M sold in total.
All 2 issuers belong to the sponsor group Viscogliosi Brothers (16 issuers, $90.6M reported sold, 2009–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Viscogliosi Brothers has 16 companies on file and $90.6M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 8 public filings for Fran Magee and found 8 differences, 2 worth asking the sponsor about: Form D filed 100 days after the first sale; Fran Magee is no longer listed on the Apr 22, 2016 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.